These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4150408)

  • 1. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S
    Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
    [No Abstract]   [Full Text] [Related]  

  • 2. Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine.
    Ahlenius S; Andén NE; Engel J
    Brain Res; 1973 Nov; 62(1):189-99. PubMed ID: 4358099
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of catecholamine synthesis during ontogenic development.
    Kellogg C; Lundborg P
    Brain Res; 1973 Oct; 61():321-9. PubMed ID: 4149305
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ; Littleton JM; Oritz A; Brownlee G
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of tyrosine hydroxylase and dopamine-beta-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine induced motor activity.
    Hollister AS; Breese GR; Cooper BR
    Psychopharmacologia; 1974 Mar; 36(1):1-16. PubMed ID: 4151923
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of ( 3 H)noradrenaline and ( 3 H)dopamine from field stimulated cerebral cortex slices. Effect of tyrosine hydroxylase and dopamine- -hydroxylase inhibition.
    Farnebo LO; Hamberger B; Jonsson G
    J Neurochem; 1971 Dec; 18(12):2491-500. PubMed ID: 4400156
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the behavioural and biochemical interaction between caffeine and L-DOPA.
    Strömberg U; Waldeck B
    J Neural Transm; 1973; 34(4):241-52. PubMed ID: 4359657
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia.
    Hökfelt T; Ljungdahl A; Fuxe K; Johansson O
    Science; 1974 Apr; 184(4133):177-9. PubMed ID: 4856104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of changes in brain monoamine metabolism on behaviour of herpes simplex-infected mice.
    Lycke E; Roos BE
    J Neurol Sci; 1974 Jul; 22(3):277-89. PubMed ID: 4151982
    [No Abstract]   [Full Text] [Related]  

  • 10. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of DOPA on the visual-evoked potentials in rabbit and on mouse motor behavior following inhibition of dopamine-beta-hydroxylase.
    Sabelli HC; Giardina WJ; Myles SB; Vazquez AJ
    Arzneimittelforschung; 1974 Mar; 24(3):333-7. PubMed ID: 4407412
    [No Abstract]   [Full Text] [Related]  

  • 12. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat.
    Dolphin A; Jenner P; Marsden CD
    J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100
    [No Abstract]   [Full Text] [Related]  

  • 13. A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.
    Andén NE; Fuxe K
    Br J Pharmacol; 1971 Dec; 43(4):747-56. PubMed ID: 4339882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 15. Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats.
    Olson L; Seiger A; Fuxe K
    Brain Res; 1972 Sep; 44(1):283-8. PubMed ID: 4403485
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism by DL-threo-DOPS of the suppression of a conditioned avoidance response induced by a dopamine-beta-hydroxylase inhibitor.
    Ahlenius S; Engel J
    J Neural Transm; 1973; 34(4):267-77. PubMed ID: 4359658
    [No Abstract]   [Full Text] [Related]  

  • 17. Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase.
    Corrodi H; Fuxe K; Hökfelt T
    Life Sci; 1966 Apr; 5(7):605-11. PubMed ID: 5960198
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse.
    Wenger GR; Stitzel RE; Craig CR
    Neuropharmacology; 1973 Jul; 12(7):693-703. PubMed ID: 4147164
    [No Abstract]   [Full Text] [Related]  

  • 19. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of centrally mediated hypotensive action of methyldopa and DOPA in cats.
    Torchiana ML; Lotti VJ; Clark CM; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):103-13. PubMed ID: 4148405
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.